Trilobio

After sprinting for months, we are thrilled to announce that Trilobio made the 2024 Forbes 30 Under 30 list! "a testament to the incredible dedication and ingenuity of our team." We are so excited to keep serving some of the most incredible minds on the planet.

Today Trilobio officially comes out of stealth, unveiling our lab automation platform to the world and highlighting three successful customer deployments (link to the press release in the comments). Our CEO Roya Amini-Naieni held a press conference at #SLAS2025 with select media who learned about Trilobio’s founding story, got a first look at our platform capabilities, and heard about how Trilobio is already helping leading biologists execute their research. Trilobio’s mission is to automate biology research for everyone, eliminating human error from the field and solving the reproducibility crisis. We’ve built a whole lab automation platform that combines our innovative robot (affectionately called the Trilobot), various lab devices, and groundbreaking research protocol software. We are currently deployed in the labs of Aaron Leconte, Monica Schwartz, and Lorenzo D'Amico, helping them save time and achieve better accuracy and consistency…all through the power of Trilobio’s lab automation platform. Read their success stories in our press release (linked in the comment below). Big thanks to our customers for their support and testimonials! It means so much to us. Argon Ventures Bob Mason Andy Feinberg Jenn Buechel Kristin Ellis Lowercarbon Capital Jennifer Kan, PhD Juniper 1517 Fund Danielle Strachman Nick Arnett Zak Slayback Alec Nielsen Maximilian Schwarz Dr. Isabella Fandrych Nucleus Capital Aaron Suri Sridhar Iyengar Alison Hirukawa, PhD Triton Bio Richard Yu Abalone Bio Josie Zayner Cathy Tie Marcell Simon Bryan Briney Scott Harris Elisabeth Garvin 776 Foundation Alexis Ohanian Sr. Shuo Yang Eric Helfgott Aravinda Seshadri (she/her) Forbes

Good afternoon #SLAS2025! Feeling that 2PM post-lunch energy slump? Visit Trilobio at Booth 2115 for a ?? hot espresso. Single or double shots. Vanilla, caramel, or hazelnut flavors. Come by for a pick-me-up and to see our robots in action. (We still have some stickers left too.)

Booth 2115 at #SLAS2025 has coffee! Come by to have an espresso and talk about robots!

Redesigning Synthetic Biology with Automation: The Future of Lab Work? Synthetic biology is at a turning point, with automation set to revolutionize the field. The traditional lab process—Design, Build, Test, Learn—has been heavily reliant on manual, repetitive tasks. But what if we could outsource these tasks to robots? In this new SynBioBeta Insights article, Jennifer Tsang, sat down with Trilobio and Emerald Cloud Lab, two companies leading the charge in this transformation. Trilobio’s modular robots, known as trilobots, are designed for minimal human intervention, seamlessly snapping together like Lego pieces. Meanwhile, Emerald Cloud Lab offers a centralized, remote-controlled lab, allowing scientists to perform experiments from anywhere in the world. Read the full article to explore how these companies are reshaping the landscape of synthetic biology: https://lnkd.in/ev2cV-CJ These innovations are breaking down the barriers to automation adoption, reducing costs, simplifying processes, and increasing reproducibility. As Roya Amini-Naieni, CEO of Trilobio, suggests, the day may soon come when biologists no longer need to pipette manually. And as Brian Frezza, co-CEO of Emerald Cloud Lab, explains, centralizing automation could make labs more accessible and user-friendly for researchers of all technical levels. ??How will these advancements impact the future of synthetic biology? Will automation become the norm, freeing scientists to focus on more creative and complex tasks? #SyntheticBiology #Automation #Biotech #Innovation #LaboratoryAutomation #AI #FutureOfWork

The support and value that we have received from 776 Foundation is unmatched. Anyone who is passionate, serious, driven, and full of grit towards solving the climate crisis, should apply.